Mediclinic International PLC to Issue Dividend of GBX 3.20 (MDC)
Mediclinic International PLC (LON:MDC) declared a dividend on Thursday, November 16th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, December 7th will be paid a dividend of GBX 3.20 ($0.04) per share on Monday, December 18th. This represents a yield of 0.61%. The ex-dividend date is Thursday, December 7th. The official announcement can be accessed at this link.
Shares of Mediclinic International (MDC) traded down GBX 7 ($0.09) during midday trading on Friday, reaching GBX 558.50 ($7.48). The company’s stock had a trading volume of 2,517,817 shares, compared to its average volume of 2,410,000. Mediclinic International has a fifty-two week low of GBX 495.40 ($6.63) and a fifty-two week high of GBX 890.18 ($11.92).
Several analysts have weighed in on the company. Citigroup reaffirmed a “neutral” rating on shares of Mediclinic International in a report on Tuesday, October 24th. J P Morgan Chase & Co cut Mediclinic International to a “neutral” rating and lowered their price target for the company from GBX 898 ($12.03) to GBX 733 ($9.82) in a report on Thursday, October 19th. Credit Suisse Group raised their price target on Mediclinic International from GBX 265 ($3.55) to GBX 305 ($4.08) and gave the company a “neutral” rating in a report on Thursday, October 26th. Jefferies Group reaffirmed an “underperform” rating and issued a GBX 550 ($7.37) price target on shares of Mediclinic International in a report on Friday, October 27th. Finally, Macquarie reaffirmed a “neutral” rating and issued a GBX 660 ($8.84) price target on shares of Mediclinic International in a report on Thursday, October 26th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company. Mediclinic International currently has a consensus rating of “Hold” and a consensus target price of GBX 708.78 ($9.49).
Mediclinic International Company Profile
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Stock Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related stocks with our FREE daily email newsletter.